Want to see OPCH full AI Analyst Report?
Option Care Health (OPCH) Ratios
Option Care Health Ratios
OPCH's free cash flow for Q2 2026 was $192.64M. For the 2026 fiscal year, OPCH's free cash flow was increased by $9.05M and operating cash flow was $183.59M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.53 | 1.70 | 1.77 | 1.76 | 1.55 |
| Quick Ratio | 0.96 | 1.20 | 1.33 | 1.36 | 1.15 |
| Cash Ratio | 0.28 | 0.53 | 0.56 | 0.52 | 0.26 |
| Solvency Ratio | 0.13 | 0.14 | 0.17 | 0.12 | 0.12 |
| Operating Cash Flow Ratio | 0.31 | 0.41 | 0.60 | 0.47 | 0.45 |
| Short-Term Operating Cash Flow Coverage | 38.12 | 49.66 | 15.29 | 10.54 | 8.31 |
| Net Current Asset Value | $ -864.41M | $ -694.88M | $ -812.43M | $ -851.95M | $ -1.04B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.37 | 0.36 | 0.35 | 0.36 | 0.40 |
| Debt-to-Equity Ratio | 0.96 | 0.87 | 0.82 | 0.83 | 0.99 |
| Debt-to-Capital Ratio | 0.49 | 0.46 | 0.45 | 0.45 | 0.50 |
| Long-Term Debt-to-Capital Ratio | 0.47 | 0.44 | 0.43 | 0.43 | 0.47 |
| Financial Leverage Ratio | 2.61 | 2.44 | 2.34 | 2.33 | 2.49 |
| Debt Service Coverage Ratio | 4.88 | 4.84 | 4.40 | 3.36 | 3.42 |
| Interest Coverage Ratio | 5.35 | 5.31 | 5.06 | 4.38 | 3.44 |
| Debt to Market Cap | 0.22 | 0.28 | 0.18 | 0.20 | 0.21 |
| Interest Debt Per Share | 8.25 | 7.45 | 6.86 | 6.68 | 6.76 |
| Net Debt to EBITDA | 2.50 | 2.03 | 1.74 | 2.65 | 4.12 |
| Profitability Margins | |||||
| Gross Profit Margin | 18.06% | 20.27% | 22.81% | 21.98% | 22.67% |
| EBIT Margin | 6.13% | 6.65% | 9.53% | 6.58% | 5.34% |
| EBITDA Margin | 7.38% | 7.93% | 10.98% | 8.24% | 7.34% |
| Operating Profit Margin | 5.98% | 6.44% | 7.31% | 6.09% | 5.55% |
| Pretax Profit Margin | 5.01% | 5.67% | 8.34% | 5.22% | 3.39% |
| Net Profit Margin | 3.67% | 4.24% | 6.21% | 3.82% | 4.07% |
| Continuous Operations Profit Margin | 3.67% | 4.24% | 6.21% | 3.82% | 4.07% |
| Net Income Per EBT | 73.38% | 74.69% | 74.45% | 73.17% | 120.09% |
| EBT Per EBIT | 83.72% | 88.12% | 114.03% | 85.65% | 61.04% |
| Return on Assets (ROA) | 6.01% | 6.19% | 8.02% | 4.66% | 4.78% |
| Return on Equity (ROE) | 15.65% | 15.08% | 18.79% | 10.86% | 11.90% |
| Return on Capital Employed (ROCE) | 12.87% | 12.18% | 11.61% | 9.01% | 7.74% |
| Return on Invested Capital (ROIC) | 9.33% | 9.00% | 8.57% | 6.53% | 7.66% |
| Return on Tangible Assets | 11.36% | 11.36% | 18.39% | 11.28% | 12.93% |
| Earnings Yield | 4.02% | 5.32% | 4.43% | 2.76% | 2.74% |
| Efficiency Ratios | |||||
| Receivables Turnover | 11.93 | 12.20 | 10.00 | 10.30 | 10.17 |
| Payables Turnover | 7.23 | 6.52 | 7.79 | 8.13 | 9.52 |
| Inventory Turnover | 9.83 | 10.27 | 12.12 | 13.72 | 14.52 |
| Fixed Asset Turnover | 40.58 | 23.37 | 21.01 | 21.82 | 18.46 |
| Asset Turnover | 1.63 | 1.46 | 1.29 | 1.22 | 1.18 |
| Working Capital Turnover Ratio | 11.55 | 9.82 | 9.51 | 11.61 | 14.52 |
| Cash Conversion Cycle | 17.30 | 9.53 | 19.73 | 17.13 | 22.70 |
| Days of Sales Outstanding | 30.60 | 29.92 | 36.49 | 35.45 | 35.90 |
| Days of Inventory Outstanding | 37.15 | 35.55 | 30.11 | 26.60 | 25.13 |
| Days of Payables Outstanding | 50.45 | 55.94 | 46.88 | 44.92 | 38.33 |
| Operating Cycle | 67.74 | 65.47 | 66.61 | 62.05 | 61.04 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 1.59 | 1.88 | 2.07 | 1.48 | 1.16 |
| Free Cash Flow Per Share | 1.34 | 1.68 | 1.84 | 1.28 | 1.02 |
| Dividend Paid and CapEx Coverage Ratio | 6.26 | 9.08 | 8.87 | 7.57 | 8.14 |
| Capital Expenditure Coverage Ratio | 6.26 | 9.08 | 8.87 | 7.57 | 8.14 |
| Operating Cash Flow Coverage Ratio | 0.20 | 0.27 | 0.32 | 0.23 | 0.18 |
| Operating Cash Flow to Sales Ratio | 0.05 | 0.06 | 0.09 | 0.07 | 0.06 |
| Free Cash Flow Yield | 4.20% | 7.23% | 5.46% | 4.26% | 3.58% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 24.89 | 18.86 | 22.58 | 36.20 | 36.56 |
| Price-to-Sales (P/S) Ratio | 0.91 | 0.80 | 1.40 | 1.38 | 1.49 |
| Price-to-Book (P/B) Ratio | 3.89 | 2.83 | 4.24 | 3.93 | 4.35 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 23.78 | 13.83 | 18.30 | 23.47 | 27.96 |
| Price-to-Operating Cash Flow Ratio | 19.98 | 12.31 | 16.24 | 20.37 | 24.52 |
| Price-to-Earnings Growth (PEG) Ratio | 6.12 | -1.08 | 0.28 | 5.65 | -0.02 |
| Enterprise Value Multiple | 14.89 | 12.08 | 14.51 | 19.42 | 24.40 |
| Enterprise Value | 6.21B | 4.79B | 6.85B | 6.31B | 6.16B |
| EV to EBITDA | 14.89 | 12.08 | 14.51 | 19.42 | 24.40 |
| EV to Sales | 1.10 | 0.96 | 1.59 | 1.60 | 1.79 |
| EV to Free Cash Flow | 28.58 | 16.63 | 20.80 | 27.18 | 33.65 |
| EV to Operating Cash Flow | 24.01 | 14.80 | 18.45 | 23.59 | 29.51 |
| Tangible Book Value Per Share | -1.86 | -0.89 | -2.54 | -2.82 | -3.71 |
| Shareholders’ Equity Per Share | 8.18 | 8.18 | 7.94 | 7.65 | 6.54 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.27 | 0.25 | 0.26 | 0.27 | -0.20 |
| Revenue Per Share | 34.85 | 29.13 | 24.04 | 21.78 | 19.12 |
| Net Income Per Share | 1.28 | 1.23 | 1.49 | 0.83 | 0.78 |
| Tax Burden | 0.73 | 0.75 | 0.74 | 0.73 | 1.20 |
| Interest Burden | 0.82 | 0.85 | 0.88 | 0.79 | 0.63 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.12 | 0.13 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 |
| Income Quality | 1.25 | 1.53 | 1.39 | 1.78 | 1.49 |
Currency in USD
